Biolife Solutions (BLFS) Income from Discontinued Operations (2023 - 2024)
Biolife Solutions (BLFS) posted quarterly Income from Discontinued Operations of 298000.0 for Q4 2024, down 26.27% year-over-year from 404183.91 in Q1 2024, and down 673.08% quarter-over-quarter from 52000.0 in Q3 2024.
Biolife Solutions (BLFS) Income from Discontinued Operations (2023 - 2024) Analysis & Trends
Biolife Solutions (BLFS) has reported Income from Discontinued Operations for 2 consecutive years, with 298000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Income from Discontinued Operations fell 26.27% year-over-year to 298000.0; the TTM figure through Sep 2025 stood at 298000.0 (down 325.71% YoY), while the FY2024 annual figure was 132000.0, up 43.35% from the prior year.
- Income from Discontinued Operations declined to 298000.0 in Q4 2024 per BLFS's latest filing, from 52000.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at 114000.0 in Q1 2024 and bottomed at 298000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -74.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -9.00 Mn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -298,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Dec 31, 2023 | -236,000.00 |
| Jun 30, 2023 | 3,000.00 |